BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28446761)

  • 1. Metabolic Syndrome Modulates Association between Endothelial Lipase and Lipid/Lipoprotein Plasma Levels in Acute Heart Failure Patients.
    Potočnjak I; Trbušić M; Terešak SD; Radulović B; Pregartner G; Berghold A; Tiran B; Marsche G; Degoricija V; Frank S
    Sci Rep; 2017 Apr; 7(1):1165. PubMed ID: 28446761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of SN1 lipases on plasma lipids in metabolic syndrome and obesity.
    Miksztowicz V; Schreier L; McCoy M; Lucero D; Fassio E; Billheimer J; Rader DJ; Berg G
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):669-75. PubMed ID: 24458708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density lipoprotein subfractions and influence of endothelial lipase in a healthy Turkish population: a study in a land of low high-density lipoprotein cholesterol.
    Kilic H; Atalar E; Lay I; Yazihan N; Buyukcam F; Saygisunar U; Aksoy M; Gunduz H; Akdemir R
    Scand J Clin Lab Invest; 2014 Jun; 74(4):278-84. PubMed ID: 24479875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of circulating lipoprotein lipase and adiponectin on the particle size of remnant lipoproteins in patients with diabetes mellitus and metabolic syndrome.
    Shirakawa T; Nakajima K; Yatsuzuka S; Shimomura Y; Kobayashi J; Machida T; Sumino H; Murakami M
    Clin Chim Acta; 2015 Feb; 440():123-32. PubMed ID: 25445417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between Endothelial Lipase and Apolipoprotein B-Containing Lipoproteins Differ in Healthy Volunteers and Metabolic Syndrome Patients.
    Klobučar I; Klobučar L; Lechleitner M; Trbušić M; Pregartner G; Berghold A; Habisch H; Madl T; Frank S; Degoricija V
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between Endothelial Lipase, High-Density Lipoprotein, and Endothelial Function Differ in Healthy Volunteers and Metabolic Syndrome Patients.
    Klobučar I; Stadler JT; Klobučar L; Lechleitner M; Trbušić M; Pregartner G; Berghold A; Habisch H; Madl T; Marsche G; Frank S; Degoricija V
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
    Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
    Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating PCSK9 levels are positively correlated with NMR-assessed atherogenic dyslipidaemia in patients with high cardiovascular risk.
    Guardiola M; Plana N; Ibarretxe D; Cabré A; González M; Ribalta J; Masana L
    Clin Sci (Lond); 2015 Jun; 128(12):877-82. PubMed ID: 25649668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
    Tehrani DM; Zhao Y; Blaha MJ; Mora S; Mackey RH; Michos ED; Budoff MJ; Cromwell W; Otvos JD; Rosenblit PD; Wong ND
    Am J Cardiol; 2016 Jun; 117(12):1921-7. PubMed ID: 27156827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome.
    Simons L; Tonkon M; Masana L; Maccubbin D; Shah A; Lee M; Gumbiner B
    Curr Med Res Opin; 2004 Sep; 20(9):1437-45. PubMed ID: 15383192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma lipids, lipoprotein metabolism and HDL lipid transfers are equally altered in metabolic syndrome and in type 2 diabetes.
    Silva VM; Vinagre CG; Dallan LA; Chacra AP; Maranhão RC
    Lipids; 2014 Jul; 49(7):677-84. PubMed ID: 24719245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma post-heparin lipase activities in the HERITAGE Family Study: the reproducibility, gender differences, and associations with lipoprotein levels. HEalth, RIsk factors, exercise Training and GEnetics.
    Després JP; Gagnon J; Bergeron J; Couillard C; Leon AS; Rao DC; Skinner JS; Wilmore JH; Bouchard C
    Clin Biochem; 1999 Apr; 32(3):157-65. PubMed ID: 10383074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is non-high-density lipoprotein associated with metabolic syndrome? A systematic review and meta-analysis.
    Mardi P; Abdi F; Ehsani A; Seif E; Djalalinia S; Heshmati J; Shahrestanaki E; Gorabi AM; Qorbani M
    Front Endocrinol (Lausanne); 2022; 13():957136. PubMed ID: 36176470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial lipase promotes the catabolism of ApoB-containing lipoproteins.
    Broedl UC; Maugeais C; Millar JS; Jin W; Moore RE; Fuki IV; Marchadier D; Glick JM; Rader DJ
    Circ Res; 2004 Jun; 94(12):1554-61. PubMed ID: 15117821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifestyle intervention enhances high-density lipoprotein function among patients with metabolic syndrome only at normal low-density lipoprotein cholesterol plasma levels.
    Hansel B; Bonnefont-Rousselot D; Orsoni A; Bittar R; Giral P; Roussel R; Marre M; Mohammedi K; Bruckert E; Chapman MJ; Kontush A
    J Clin Lipidol; 2016; 10(5):1172-81. PubMed ID: 27678434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein.
    Karpe F; Tornvall P; Olivecrona T; Steiner G; Carlson LA; Hamsten A
    Atherosclerosis; 1993 Jan; 98(1):33-49. PubMed ID: 8457249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low plasma apolipoprotein E-rich high-density lipoprotein levels in patients with metabolic syndrome.
    Shinohata R; Shiga Y; Miura SI; Hirohata S; Shibakura M; Ueno-Iio T; Watanabe S; Arao Y; Usui S
    Clin Chim Acta; 2020 Nov; 510():531-536. PubMed ID: 32798512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial lipase activity predicts high-density lipoprotein catabolism in hemodialysis: novel phospholipase assay in postheparin human plasma.
    Miksztowicz V; McCoy MG; Schreier L; Cacciagiú L; Elbert A; Gonzalez AI; Billheimer J; Eacho P; Rader DJ; Berg G
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):3033-40. PubMed ID: 23104846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
    Nikkilä EA; Ylikahri R; Huttunen JK
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.